Match tier Listed
Presence Current · Arkansas
Last published 2024
Sources OpenAlex · ORCID
Refreshed 2026-08-08

AbdelHai Hammo

Professor

Faculty Researcher

COM | Peds Gastroenterology

1 h-index 2 pubs 8 cited

  • Ustekinumab
  • Colitis, Ulcerative
  • Crohn Disease
  • Remission Induction
  • Inflammatory Bowel Diseases
  • Adolescent
  • Child
  • Female
  • Humans
  • Male
  • Retrospective Studies
  • Treatment Outcome

Biography and Research Information

OverviewAI-generated summary

AbdelHai Hammo's research focuses on the clinical effectiveness and safety of ustekinumab in pediatric and adolescent patients diagnosed with refractory inflammatory bowel disease. His work includes retrospective cohort studies examining treatment outcomes in these young populations. Hammo has published on the efficacy and safety of ustekinumab in youth with inflammatory bowel disease, with a particular emphasis on outcomes in specific geographic regions. His scholarship metrics include an h-index of 1 with 2 total publications and 8 total citations.

Metrics

  • h-index: 1
  • Publications: 2
  • Citations: 8

Selected Publications

  • Clinical effectiveness and safety of ustekinumab in youth with refractory inflammatory bowel disease: A retrospective cohort study (2024)
    Saudi Journal of Gastroenterology 8 citations DOI OpenAlex
  • A222 CLINICAL EFFECTIVENESS AND SAFETY OF USTEKINUMAB IN YOUTH WITH REFRACTORY INFLAMMATORY BOWEL DISEASE IN SAUDI ARABIA: A RETROSPECTIVE COHORT STUDY (2024)
    Journal of the Canadian Association of Gastroenterology DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

5 Collaborators 2 Institutions 2 Countries

Top Collaborators

Similar Researchers

Based on overlapping research topics